To make an appointment, please call 1-800-KARMANOS (1-800-527-6266) or request an appointment online
As a leader in cancer research, Karmanos is able to offer patients access to innovative treatments and clinical trials that are often times not available anywhere else.
To offer hope and longer life to patients with all types of cancer, Karmanos offers the latest types of therapy through our clinical trials program. Through clinical trials, we are creating new knowledge about how therapies fight cancer and provide national leadership in testing these new therapies.
We understand that cancer is a complex disease that demands complex care. We provide each patient with a dynamic, carefully constructed treatment plan focused on their specific cancer and their unique needs.
We listen to you to design a plan that provides you with respect, compassionate care and is responsive to your emotional and practical concerns.
Yusra F. Shao, M.D., is a recent graduate of the Hematology and Oncology fellowship at Karmanos Cancer Institute/Wayne State University where she served as chief fellow. Dr. Shao has a niche research interest in ocular melanoma and developing immune and cellular therapies. She is a member of the Cutaneous and Genitourinary Precision Oncology Alliance, and continues to publish and present her research work nationally. Dr. Shao is also passionate about promoting access to oncologic care to the underserved populations of the Detroit Metropolitan Area through her community outreach work. In her leisure time, she enjoys painting and exploring the outdoors.
Patient Power It’s estimated that about 4% of cancers that will be diagnosed in 2024 will be bladder cancer. Yusra Shao, M.D. , medical oncologist and member of the Genitourinary Oncology Multidisciplinary Team at Karmanos, explained what physicians do to understand if bladder cancer has spread to other areas of the body and the signs and symptoms of the disease. Read the article here .
The Checkup by SingleCare Coffee has its benefits, but if taking other medications, it's vital to know if adding a cup of Joe might cause side effects. Yusra Shao, M.D. , medical oncologist and member of the Genitourinary Oncology , Melanoma , and Phase 1 Clinical Trials Multidisciplinary Teams at the Barbara Ann Karmanos Cancer Institute , sometimes prescribes prednisone, a steroid, to her patients. Jelena Radan, Pharm.D., BCPS, lead clinical pharmacy specialist at KSP Specialty Pharmacy , and Dr. Shao...
Shao YF, DeBenedictis M, Yeaney G, Singh AD. Germ line BAP1 Mutation in Patients with Uveal Melanoma (UM) and Renal Cell Carcinoma (RCC). Ocular Oncology and Pathology 2021; 7:340–345 PMID: 34722490
Shao YF, Echegaray JJ, Singh N, Singh AD. Variability of Bad Prognosis in Uveal Melanoma. Ophthalmology Retina 2019
186–193. PMID: 31014770 3. Brewington BY, Shao YF, Davidorf FH, Cebulla CM. Brachytherapy for Patients with Uveal Melanoma: Historical Perspectives and Future Treatment Directions. Clinical Ophthalmology 2018; 12, 925–934. PMID: 29844657
Nagasaka M, Al-Share B, Shao YF, Sexton R, Al Hallak MN, Azmi AS, Sukari A. The Gut Microbiome and Cancer: A Comprehensive Review of Melanoma, Lung, Head and Neck and Gastrointestinal Tumors. Reference Collection in Food Science (planned for publication in the Comprehensive Gut Microbiota) Elsevier. Equal contribution as first author
Shao YF, Echegaray JJ, Singh AD. Metastatic Tumors of the Uvea. Intraocular Tumors 179–185 (Springer Singapore, 2019)